2026-03-27 Eisai Co.,Ltd. “Regarding "Lenvima®" (lenvatinib), an application has been submitted in Japan to add a new dosage and administration method for combination therapy with "Wellig®" (verzutifan) for renal cell carcinoma that has progressed after cancer chemotherapy.”

Toyota|$18.23 (¥2,915)+2.48%▲ (in JPY terms)

Sony|$22.79 (¥3,645)-0.65%▼ (in JPY terms)

SoftBank|$52.09 (¥8,329)-3.51%▼ (in JPY terms)

MUFG|$19.57 (¥3,129)+2.72%▲ (in JPY terms)

Keyence|$505.73 (¥80,870)+3.23%▲ (in JPY terms)

Nintendo|$46.63 (¥7,457)+0.42%▲ (in JPY terms)

NTT|$0.92 (¥148)+0.00%▲ (in JPY terms)

Takeda|$29.64 (¥4,740)-2.27%▼ (in JPY terms)

Tokyo Electron|$380.65 (¥60,870)+13.33%▲ (in JPY terms)

Recruit|$67.76 (¥10,835)-0.09%▼ (in JPY terms)

ITOCHU|$11.62 (¥1,858)+0.03%▲ (in JPY terms)

Honda|$9.36 (¥1,498)+7.97%▲ (in JPY terms)

Shin-Etsu|$48.62 (¥7,774)+4.03%▲ (in JPY terms)

Tokio Marine|$44.43 (¥7,105)+0.84%▲ (in JPY terms)

Fast Retailing|$494.97 (¥79,150)-0.67%▼ (in JPY terms)